SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests.
Kay GA, Owen SI, Giorgi E, Clark DJ, Williams CT, Menzies S, Cuevas LE, Davies BMO, Eckersley NM, Hughes GL, Kirwan DE, Krishna S, Patterson EI, Planche T, Staines HM, Adams ER.
Kay GA, et al. Among authors: giorgi e.
Sci Rep. 2022 Mar 1;12(1):3351. doi: 10.1038/s41598-022-07263-8.
Sci Rep. 2022.
PMID: 35233014
Free PMC article.
Clinical Trial.